OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Review of secukinumab‐induced adverse events of special interest and its potential pathogenesis
Jingyao Liang, Sanquan Zhang, Qian Li, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 8
Open Access | Times Cited: 8
Jingyao Liang, Sanquan Zhang, Qian Li, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 8
Open Access | Times Cited: 8
Showing 8 citing articles:
IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment
Meiying Song, Jie Liang, Luoyang Wang, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110757-110757
Closed Access | Times Cited: 22
Meiying Song, Jie Liang, Luoyang Wang, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110757-110757
Closed Access | Times Cited: 22
Lupus Nephritis: New and Emerging Biologic and Targeted Therapies
Ajinath Kale, Maciej Lech, Hans‐Joachim Anders, et al.
BioDrugs (2023) Vol. 37, Iss. 4, pp. 463-475
Closed Access | Times Cited: 13
Ajinath Kale, Maciej Lech, Hans‐Joachim Anders, et al.
BioDrugs (2023) Vol. 37, Iss. 4, pp. 463-475
Closed Access | Times Cited: 13
Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real‐world practice
Jian Zhou, Yuan Yuan, Yanhua Liu, et al.
Experimental Dermatology (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 8
Jian Zhou, Yuan Yuan, Yanhua Liu, et al.
Experimental Dermatology (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 8
The unexpected guest: Cytotoxic, pseudolymphoma‐like reaction at the site of primary cutaneous follicle centre B‐cell lymphoma in a patient receiving secukinumab for psoriasis
Carlo Pescia, Gian Andrea Pini, Silvia Tabano, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 8
Closed Access | Times Cited: 1
Carlo Pescia, Gian Andrea Pini, Silvia Tabano, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 8
Closed Access | Times Cited: 1
Serious adverse events associated with systemic treatments for psoriasis: a network meta-analysis of observational studies and randomized controlled trials
Robin Guelimi, Anna Chaimani, Rosa Parisi, et al.
Cochrane library (2024) Vol. 2024, Iss. 4
Open Access | Times Cited: 1
Robin Guelimi, Anna Chaimani, Rosa Parisi, et al.
Cochrane library (2024) Vol. 2024, Iss. 4
Open Access | Times Cited: 1
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence
Piergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Dermatology and Therapy (2024)
Open Access
Piergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Dermatology and Therapy (2024)
Open Access
A Case of Psoriasis Secondary to Tinea Corporis Treated with Skuclizumab and Review of Related Literature
Qingli Zou, Yan Zhou, Shuxian Shang, et al.
Case Reports in Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 597-603
Open Access
Qingli Zou, Yan Zhou, Shuxian Shang, et al.
Case Reports in Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 597-603
Open Access
Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
Jarosław Nowakowski, Anna Tomoń, Dorota Telesińska-Jasiówka, et al.
Central European Journal of Immunology (2023) Vol. 48, Iss. 4, pp. 346-349
Open Access | Times Cited: 1
Jarosław Nowakowski, Anna Tomoń, Dorota Telesińska-Jasiówka, et al.
Central European Journal of Immunology (2023) Vol. 48, Iss. 4, pp. 346-349
Open Access | Times Cited: 1
